Oracle's Cloud Engine Roars While the Cash Register Runs Dry
Published on 09/23/2026 at 07:11 | Editorial boerse-global.de
Oracle's transformation from a legacy software vendor into a hard-hat infrastructure builder reached a new milestone this week, but the numbers behind the headline tell a story of extraordinary growth colliding with equally extraordinary spending.
The Austin-based company disclosed that Arvato Systems will run the European Medicines Verification System on its Oracle EU Sovereign Cloud. The platform tracks pharmaceuticals across the continent to keep counterfeit medicines out of European supply chains — a high-stakes assignment in a heavily regulated sector where data must never leave the bloc. For Oracle, the win is a credibility marker in its push to court European enterprises that prize digital sovereignty above all else.
Investors greeted the news with modest buying. Oracle shares added 1.1% in German trading to reach EUR 130.98, though the stock remains down 21% year-to-date.
A Quarter of Extremes
The operating picture Oracle presented on September 10 for the first quarter of fiscal 2027 cuts both ways. Revenue climbed 30% to $19.3 billion. Cloud infrastructure revenue — the segment doing the heaviest lifting in the AI era — surged 121% year-over-year to $7.4 billion, with more than 300,000 GPUs installed and running at 97.9% utilization.
Management, led by Executive Chair Larry Ellison, raised the bar further: full-year fiscal 2027 revenue is now targeted at no less than $90 billion, with adjusted earnings per share projected at $8.10.
Should investors sell immediately? Or is it worth buying Oracle?
Product momentum has kept pace. Java 27 arrived on September 15 with new artificial intelligence features and post-quantum cryptography. A day earlier, the Clinical AI Agent for nurses handling clinical documentation went live in the United States.
Where the Money Goes
Beneath those impressive top-line figures lies a structural shift that has unsettled parts of Wall Street. Software was once a low-capital, high-margin business. Building data centers is neither.
Oracle generated a record operating cash flow of $23 billion in the opening quarter — and spent $28 billion on capital expenditures. The result: free cash flow of negative $5 billion. For the full fiscal year, management has penciled in investments of $90 billion to $95 billion. Every dollar collected, it seems, is promptly poured into concrete, cooling systems, and server racks.
The capital intensity has prompted analysts to trim their targets. BMO Capital Markets cut its price target on September 11 from $220.00 to $195.00 while keeping an "Outperform" rating. Freedom Broker lowered its target on September 14 from $210.00 to $205.00.
Restructuring and Restraint
The expansion comes with a counterweight. Roughly a week ago, management raised the cost of its restructuring plan for fiscal 2026 by about $700 million, bringing the total to approximately $2.8 billion. The program includes job cuts — a detail that factored into the cautious target revisions from analysts, even as most houses maintained a broadly positive stance on the stock.
Oracle is also pushing ahead with large-scale projects alongside partners, including Project Lighthouse, a new data center campus in Wisconsin. The company is simultaneously courting local goodwill through investments in educational initiatives.
Oracle at a turning point? This analysis reveals what investors need to know now.
Ellison offered his own signal of conviction roughly two weeks ago by canceling a planned share sale, and he has not indicated any intention to sell since. That gesture did little to dispel the broader skepticism.
The Market's Verdict
The share price reflects months of mounting doubt. Yesterday's close of EUR 130.40 leaves the stock down 22% since the start of the year and 53% below its 52-week high.
Oracle supplies the technological backbone for the generative AI era, and its operational capacity is running near its limits. A quarterly dividend of $0.50 per share is scheduled for payout on October 23, as usual. But until the enormous investment pile begins converting into durable free cash, the equity will remain exposed to the market's persistent questions about whether the spending will ultimately pay off.
Ad
Oracle Stock: New Analysis - 23 September
Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
